I agree that this site is using cookies. You can find further informations here.
X
Ray-Coquard, I.L.
575  results:
Search for persons X
?
1

53P Description of BRCA mutated high-grade ovarian cancer d..:

Leary, A. ; Fouquier, A. ; Ray-Coquard, I.L....
ESMO Open.  9 (2024)  - p. 103560 , 2024
Link: https://doi.org/10.1016/..
 
?
2

59MO COTESARC – A multicentre, phase I-II clinical trial ev..:

Dufresne, A. ; Brahmi, M. ; Cropet, C....
ESMO Open.  9 (2024)  - p. 102449 , 2024
Link: https://doi.org/10.1016/..
 
?
3

46MO What are the predictors of the success of interval deb..:

Marchetti, C. ; Colomban, O. ; Fagotti, A....
ESMO Open.  9 (2024)  - p. 103553 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Should all advanced BRCA-mutated patients in response to fi..:

Turinetto, M. ; Ray-Coquard, I. ; Gourley, C.
ESMO Open.  9 (2024)  5 - p. 102983 , 2024
Link: https://doi.org/10.1016/..
 
?
5

VP3-2024: A randomized study of 6 vs 3 years of adjuvant im..:

Le Cesne, A. ; Schiffler, C. ; Bouche, O....
Annals of Oncology.  35 (2024)  6 - p. 576-577 , 2024
Link: https://doi.org/10.1016/..
 
?
6

59P Real-world effectiveness of niraparib in recurrent ovar..:

Hanvic, B. ; Macouillard, P. ; Gladieff, L....
ESMO Open.  9 (2024)  - p. 103566 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Valeur pronostique de la cinétique précoce de l'ADN tumoral..:

Azais, H. ; Brochard, C. ; Benoit, L....
Gynécologie Obstétrique Fertilité & Sénologie.  52 (2024)  5 - p. 348-349 , 2024
Link: https://doi.org/10.1016/..
 
?
8

55O IMADGIST: A randomized study of 6 vs 3 years of adjuvan..:

Le Cesne, A. ; Chabaud, S. ; Bouche, O....
ESMO Open.  9 (2024)  - p. 102445 , 2024
Link: https://doi.org/10.1016/..
 
?
9

19P Long-term fatigue after treatments for non-epithelial o..:

Dubot, C. ; Ray-Coquard, I.L. ; Pautier, P....
ESMO Open.  9 (2024)  - p. 102558 , 2024
Link: https://doi.org/10.1016/..
 
?
10

34O ROCSAN: A multicentric randomized phase II/III evaluati..:

Ray-Coquard, I.L. ; Bellesoeur, A. ; Fabbro, M....
ESMO Open.  9 (2024)  - p. 103534 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Improved nationwide survival of sarcoma patients with a net..:

Blay, J.Y. ; Penel, N. ; Valentin, T....
Annals of Oncology.  35 (2024)  4 - p. 351-363 , 2024
Link: https://doi.org/10.1016/..
 
?
12

52O Resistance to imatinib induced by treatment interruptio..:

Blay, J-Y. ; Devin, Q. ; Duffaud, F....
ESMO Open.  9 (2024)  - p. 102442 , 2024
Link: https://doi.org/10.1016/..
 
?
13

82MO European multi-disciplinary tumor boards within the EU..:

Bergamini, A. ; Joneborg, U. ; Marquina, G....
ESMO Open.  9 (2024)  - p. 103542 , 2024
Link: https://doi.org/10.1016/..
 
?
14

32O 5-year (y) overall survival (OS) with maintenance olapa..:

Lorusso, D. ; Mouret-Reynier, M-A. ; Harter, P....
ESMO Open.  8 (2023)  1 - p. 100812 , 2023
Link: https://doi.org/10.1016/..
 
?
15

64P Tertiary lymphoid structure and efficacy of doxorubicin..:

Grassi, M. ; Dufresne, A. ; Karanian, M....
ESMO Open.  8 (2023)  1 - p. 101101 , 2023
Link: https://doi.org/10.1016/..
 
1-15